SBIO | ALPS Medical Breakthroughs ETF Overview

(Stock Exchange: AMEX)

Day's Range	32.61 - 33.00
52 Week Range	30.07 - 42.73
Beta	0.91
Implied Volatility	34.36%
IV Rank	22.84%
Day's Volume	12,505
Average Volume	12,905
Shares Outstanding	3,137,677
Inception Date	2014-12-31

Assets	119,156,809
Asset Class	Equity
Expense Ratio	0.50
P/E Ratio	N/A
EPS	N/A
Dividend Yield	3.60%
Dividend Per Share	1.18
Dividend ExDate	N/A
Dividend PayDate	N/A

The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.

*Chart delayed

Watching at SBIO technicals we can see that long-term trend is bearish, the same as bearish middle-term trend, as well as bearish short-term trend. More technicals details can be found on SBIO Technicals page.